1Brines ML, Ghezzi P, Keenan S, et al. Erythropoietin crosses the blood - brain barrier to protect asainst experimental brain injury [J]. Proc NatlAcad Sei USA,2000,97(19):230- 251.
2Benraudin M, Marti HH, Roussel S, et al. A potential role for erythropoietin in focal permanent cerebral ischemia in mice [ J ]. Cereb Blood Flow Metab, 1999,19 (6) :643 - 651.
3Grasso G, Buemi M, Alafaci C, et al. Beneficial effects of systemic administration of recombinant human erythropoietin in rabbits subjected to subarachnoid hemorrhage [ J]. Proc Natl Acad Sci USA, 2002, 99 : 5 627 - 5 637.
4Lai PH, Everett R, Wang FF,et al. Structural characterization of human erythropoietin [ J ]. Biol Chem, 1986,261 ( 7 ) : 3 116 - 3 121.
5Jelkmann W. The enigma of the metabolic fate of circulating erythropoietin(EPO) in view of the pharmacokinetics of the recombinant drugs rHu - EPO and NESP [ J ]. Eur J Haematol,2002,69 : 265 - 274.
7Juul SE. EPO in the neonate [ J]. Curr Probl Pediatr, 1999,29 (5) :129 - 149.
8Masuda S,Okano M ,Yamagishi K,et al. A novel site of erythropoietin production. Oxygen - dependent production in cultured rat astoreytes[ J]. J Biol Chem,1994,269(30) :19 488 - 19 493.
9Juul SE,Yachnis AT, ROjiani AM, et al. Immunohistochemical localization of erythropoietin and its receptor in the developing human brain[J]. Pediatr Dev Pathol,1999,2(2) :148 -158.
10ChungYH, Kim SI, JooK M, et al. Age - related changes in erythropoietin immunoreactivity in the cerebral cortex and hippocampus of rats[ J]. Brain Res,2004,154( 1 ) : 141 - 146.
二级参考文献33
1Mauney MC, Blackborume LH, Lahgenburg SE, et al. Prevention of spinal cord injury after repair of the thoracic or thoracoabdominal arorta [ J ]. Ann Thorac Surg, 1995,59 ( 1 ): 245 ～ 252.
2Yasuda Y, Nagao M, Okano H, et al. Localization of erythropoietin and erythropoietin-receptor in postimplantation mouse embryos [ J ]. Dev Growth Differ, 1993,35,711 ～ 722.
3Buemi M, Aloisi C, Cavallaro E, et al. Recombinant human erythropoietn(rHuEPO) :More than just the correction of uremic anemia[J]. J Nephrol,2002,15:97 ～ 103.
4Gorio A, Gokmen N, Erbayraktar S, et al. Recombinant human erythropoietin counteracts secondary injury and mark enhances neurological recovery from experimental spinal cord trauma [ J ]. PNAS, 2002,99(14) :9450～9455.
5Celk M, Gokmen N, Erbayraktar S,et al. Erythropoietin prevents motor neuron apoptosis and meurologic disability in experimental spinal cord ischemic injury[J]. PNAS. 2002,99(4) :2258 ～ 2263.
6Aydin A, Genc K, Akhisaroglu M, et al. Erythropoietin exerts neuroprotective effect in neonatal rat model of hypoxic-ischemic brain injury[ J ]. Brain & Development,2003,1 ～ 5.
7Vannucci RC, Perlman JM. Interventions for perinatal hypoxic-ischemic encephalopathy[J]. Pediatrics, 1997,100:1004 ～ 1014.
8Sakanaka M, Wen TC, Matsuda S,et al. IN vivo evidence that erythropoietin protectx neurons from ischemic damage[J]. Proc Natl Acad Sci USA, 1998,95:4635 ～ 4640.
9Boise LH, Gonzalez-Garcia M, Postema CE, et al. Bcl-x, bcl-2-related gene that functions as a dominant regulator of apoptotic cell death[J].Cell, 1993,74:597 ～ 608.
10Juul SE,Anderson DK,Li Y,et al. Erythropoietin and erythropoietin receptor in the developing human central nervous systen [ J ]. Pediatr Res, 1998,43:40 ～ 49.
